Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Lloyds and PDA agreed on pay settlement for store pharmacists

Lloyds Pharmacy has offered three per cent increase in base pay backdated to 1 April for its store pharmacists, the union of Pharmacists’ Defence Association (PDAU) who represented them has announced.

“We are pleased to announce that following a consultation of its members, the PDAU has informed the company that agreement can be reached on the company’s latest offer, made in July 2022,” said the PDAU.


The offer made by the company also includes introduction of an overtime rate of 1.5 times basic pay for each hour worked after contracted hours. This will run for a trial period and be reviewed as part of the next pay round.

“All pharmacists will receive an initial £1,000 payment under the proposed LTIP scheme, paid in April 2024. This will be to all in the bargaining unit and will not be dependent on meeting any criteria such as targets,” said PDAU.

“In addition, the company will introduce a Long-Term Incentive Plan which will see additional payments made to those paid under any existing bonus arrangements.”

Kevin Birch, chief retail officer at Lloyds Pharmacy, commented: “Our pharmacists are really important to us, and we are delighted to reach an agreement with them through our discussions with the PDAU. This is the first round of pay negotiations between Lloyds Pharmacy and the PDAU and we are pleased with how the process has worked and that we have ultimately reached a mutually agreeable outcome.

"This pay offer will see all eligible pharmacists receive an increase in their base pay, as well as overtime rates. We are also delighted to be introducing a market-leading long-term incentive plan that will give colleagues the opportunity to significantly enhance their earnings, by sharing in the success of the branch they are working in and their loyalty and tenure with Lloyds Pharmacy.”

Paul Moloney, PDAU national officer and lead negotiator, commented: “We welcome this agreement, the first of its kind between the PDAU and LloydsPharmacy and place on record our acknowledgement of the company’s efforts to work with us to achieve this agreement. Although falling short of the current inflation figures this nevertheless represents the highest increase many members will have seen in recent years.”

More For You

NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less